Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5272588
Max Phase: Preclinical
Molecular Formula: C42H54Cl2N2O16
Molecular Weight: 913.80
Associated Items:
ID: ALA5272588
Max Phase: Preclinical
Molecular Formula: C42H54Cl2N2O16
Molecular Weight: 913.80
Associated Items:
Canonical SMILES: CO[C@@H]1[C@H](O[C@@H]2CO[C@@H](O[C@@H]3[C@@H](O)[C@H](O)CO[C@H]3N3C(=O)/C(=C(O)/C=C/C=C/C=C/C=C/C=C(Cl)/C=C/C=C/[C@@H]4O[C@H](C)C[C@@H]4Cl)C(=O)[C@@H]3CC(N)=O)[C@@H](O)[C@@H]2O)O[C@H](C)[C@H]1O
Standard InChI: InChI=1S/C42H54Cl2N2O16/c1-21-17-24(44)28(59-21)16-12-11-14-23(43)13-9-7-5-4-6-8-10-15-26(47)31-33(51)25(18-30(45)49)46(39(31)55)40-37(34(52)27(48)19-57-40)62-41-36(54)35(53)29(20-58-41)61-42-38(56-3)32(50)22(2)60-42/h4-16,21-22,24-25,27-29,32,34-38,40-42,47-48,50,52-54H,17-20H2,1-3H3,(H2,45,49)/b5-4+,8-6+,9-7+,14-11+,15-10+,16-12+,23-13-,31-26-/t21-,22-,24+,25+,27-,28+,29-,32-,34+,35-,36+,37-,38+,40-,41+,42+/m1/s1
Standard InChI Key: ZKJYYAOTFJQDHK-BPDAUPLASA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 913.80 | Molecular Weight (Monoisotopic): 912.2850 | AlogP: 0.75 | #Rotatable Bonds: 16 |
Polar Surface Area: 266.46 | Molecular Species: ACID | HBA: 16 | HBD: 7 |
#RO5 Violations: 3 | HBA (Lipinski): 18 | HBD (Lipinski): 8 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 5.07 | CX Basic pKa: | CX LogP: 0.63 | CX LogD: -1.68 |
Aromatic Rings: 0 | Heavy Atoms: 62 | QED Weighted: 0.04 | Np Likeness Score: 1.60 |
1. Govindarajan M.. (2018) Amphiphilic glycoconjugates as potential anti-cancer chemotherapeutics., 143 [PMID:29126728] [10.1016/j.ejmech.2017.10.015] |
Source(1):